Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI2007323 |
Pages: 180 |
Jan 2023 |
The global HLA typing for the transplant market will witness significant growth due to a rise in the amount of transplant procedures and an increase in technological advancements in the field of HLA typing.
Human leukocyte antigen (HLA) typing is often used to match blood cells or bone marrow transplant of patient’s with donors. As transplant complications increase, there is a growing urgency to balance the viability of organ transplantation before the surgery to prevent any damage. Matching HLA assists to grow and develop new blood cells and eliminates the risk of adverse effects after transplantation.
Increasing R&D activities in the pharmaceutical and biotechnology industry are attributing the market growth for the global HLA typing for the transplant market. An increasing number of resources invested by the government, as well as the private business firms in the global HLA typing market, are equally contributing towards the market growth.
Strict government regulations for organ donations and transplantation could hamper market growth. In addition, organ transplant devices are very expensive, and there are only a few organ donations and transplantation centers, these factors restrain the growth of the global HLA typing for the transplant market.
Technological advancements will further create several opportunities for propelling development in the global HLA typing for the transplant market. Advancement in health care facilities around developing countries poses significant business growth prospects for the market. In addition, growing public-private investment for product innovation is also anticipated to generate enormous opportunities for the market.
By technology, the HLA typing for the transplant market is divided into the non-molecular assay, molecular assay, next-generation sequencing, and sanger’s sequencing. Amongst these, molecular assay dominates the market share and is expected to continue till 2027. This is due to various benefits offered by molecular assays such as small processing time, high procedural efficiency, multi-sample test, and real-time data interpretation.
By product & service, the HLA typing for the transplant market is segmented into instruments, reagents & consumables, and software & services. Out of these, the instrument segment has the largest market share attributing to the rising usage of developed instruments, which assists in providing better and accurate results.
By application, the HLA typing for the transplant market is classified into diagnostics and research. Diagnostic application is used to match organ and transplantation donors with patients. It has the largest market share, as this technique is used commonly. In addition, an increasing number of organ donations and transplants will contribute towards market growth.
By end-users, the HLA typing for the transplant market is bifurcated into hospitals, academic & research institutes, and commercial service providers. Amongst these, the hospital sector dominated the market share and is anticipated to continue until 2027. The hospital sector leads the market due to the availability of advanced medical equipment and skilled personnel that enables treating patients efficiently and provides accurate results on time. HLA typing for transplant is more commonly used in hospitals and health sectors than other end-users owing to its increasing number of the patient count with the rising population.
The global HLA typing for the transplant market is analyzed across North America, Europe, Asia-Pacific, and LAMEA regions. North America dominates the market share of the HLA typing for the transplant market owing to the increasing number of organ transplant procedures and rising life expectancy rates. Asia-Pacific is anticipated to be the fastest-growing region due to the increasing adoption of advanced technology and medical devices.
To explore more about Global HLA Typing for Transplant Market, get in touch with our analysts here.
https://www.researchdive.com/connect-to-analyst/323
Key Participants in the Global HLA Typing for Transplant Market:
Merger & acquisition and advanced product development are the frequent strategies followed by the market players
Some of the major key players in the global HLA typing for transplant market are Thermo Fisher Scientific, Qiagen, Illumina Inc., CareDx Inc., Immucor Inc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc., Luminex Co., Biofortuna, and others.
Market Players prefer inorganic growth strategies to expand into local markets.HLA typing for transplant market players are emphasizing more on merger & acquisition and advanced product development. These are the various strategies followed by established organizations. To emphasize more on the competitor analysis of market players,Porter’s five forces model is explained in the report.
|
Aspect |
Particulars |
|
Historical Market Estimations |
2018-2019 |
|
Base Year for Market Estimation |
2019 |
|
Forecast timeline for Market Projection |
2020-2027 |
|
Geographical Scope |
North America, Europe, Asia-Pacific, LAMEA |
|
Segmentation by Technology |
|
|
Segmentation by Product & Service |
|
|
Segmentation by Application |
|
|
Segmentation by End-User |
|
|
Key Countries Covered |
U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia |
|
Key Companies Profiled |
|
Source: Research Dive Analysis
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization
